Massive gastrointestinal bleeding in a patient with COVID-19

Area of Science:

• Internal Medicine
• Hematology
• Infectious Diseases

Background:

• The relationship between COVID-19 and coagulation disorders is under investigation.
• COVID-19 is associated with a cytokine storm, leading to hypercoagulable states and thromboembolic complications.
• Emerging data suggest a thrombophilic effect of SARS-CoV-2.

Observation:

• Severe COVID-19 patients face an increased risk of gastrointestinal bleeding.
• The novel coronavirus may infect gastrointestinal epithelial cells and vascular endothelium.
• This case report details gastrointestinal bleeding in a patient with severe COVID-19.

Findings:

• COVID-19 can induce immune thrombocytopenia and disseminated intravascular coagulation (DIC).
• The presented case highlights a potential link between severe COVID-19 and DIC.
• COVID-19 disease is hypothesized as a predominant factor for DIC and GI bleeding.

Implications:

• Further research is needed to understand the link between COVID-19 and GI bleeding.
• This case underscores the potential for COVID-19 to precipitate serious bleeding complications.
• Understanding these mechanisms is crucial for managing COVID-19 patients with bleeding risks.